AR221717A1 - Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona - Google Patents
Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-dionaInfo
- Publication number
- AR221717A1 AR221717A1 AR275802A AR27580279A AR221717A1 AR 221717 A1 AR221717 A1 AR 221717A1 AR 275802 A AR275802 A AR 275802A AR 27580279 A AR27580279 A AR 27580279A AR 221717 A1 AR221717 A1 AR 221717A1
- Authority
- AR
- Argentina
- Prior art keywords
- propionyloxi
- butyryloxi
- hidroxi
- diona
- pregnen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53036251A JPS6040439B2 (ja) | 1978-03-29 | 1978-03-29 | ヒドロコルチゾン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR221717A1 true AR221717A1 (es) | 1981-03-13 |
Family
ID=12464544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR275802A AR221717A1 (es) | 1978-03-29 | 1979-03-14 | Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona |
Country Status (11)
Country | Link |
---|---|
US (1) | US4290962A (es) |
JP (1) | JPS6040439B2 (es) |
AR (1) | AR221717A1 (es) |
CH (1) | CH638227A5 (es) |
DE (1) | DE2910899C2 (es) |
FR (1) | FR2421180A1 (es) |
GB (1) | GB2020291B (es) |
IT (1) | IT1116531B (es) |
KE (1) | KE3481A (es) |
MY (1) | MY8500791A (es) |
SG (1) | SG55584G (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2826257C3 (de) * | 1978-06-15 | 1980-12-04 | Beiersdorf Ag, 2000 Hamburg | Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt |
ATE12237T1 (de) * | 1980-12-23 | 1985-04-15 | Schering Ag | Neue 6-alpha-methylhydrocortison-derivate, ihre herstellung und verwendung. |
DE3133081A1 (de) * | 1981-08-18 | 1983-03-10 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung |
AT389447B (de) * | 1983-01-27 | 1989-12-11 | Taisho Pharmaceutical Co Ltd | Verfahren zur herstellung einer topischen steroidsalbe |
JPS59137408A (ja) * | 1983-01-27 | 1984-08-07 | Taisho Pharmaceut Co Ltd | 軟膏 |
JPS59139315A (ja) * | 1983-01-31 | 1984-08-10 | Taisho Pharmaceut Co Ltd | クリ−ム剤 |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
WO2006071794A2 (en) | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
EP1641913B1 (en) | 2003-06-27 | 2016-01-06 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
AU2004268847A1 (en) * | 2003-08-29 | 2005-03-10 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-IV |
US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
EP1934219A1 (en) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
JP2009512676A (ja) | 2005-10-19 | 2009-03-26 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性受容体アンタゴニストの医薬組成物 |
EP1948167A1 (en) * | 2005-10-19 | 2008-07-30 | Ranbaxy Laboratories, Ltd. | Compositions of phosphodiesterase type iv inhibitors |
WO2007070870A1 (en) | 2005-12-16 | 2007-06-21 | Ethicon, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
US20100029728A1 (en) * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
AU2007298549A1 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-IV |
ES2524443T3 (es) | 2006-11-13 | 2014-12-09 | DePuy Synthes Products, LLC | Expansión in vitro de células postparto usando microportadores |
EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
AU2008224541B2 (en) * | 2007-03-14 | 2013-08-22 | Sun Pharmaceutical Industries Limited | Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
WO2008111009A1 (en) * | 2007-03-14 | 2008-09-18 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
CN102387807A (zh) * | 2008-12-19 | 2012-03-21 | 先进科技及再生医学有限责任公司 | 肺部疾病和病症的治疗 |
CN104356188A (zh) * | 2014-10-23 | 2015-02-18 | 华中药业股份有限公司 | 一种丁酸氢化可的松的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH429716A (de) * | 1961-06-24 | 1967-02-15 | Vismara Francesco Spa | Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden |
GB1043347A (en) * | 1963-05-10 | 1966-09-21 | Glaxo Lab Ltd | 17,21-orthoesters of steroids |
GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
US3422193A (en) * | 1966-08-11 | 1969-01-14 | Schering Corp | 17-mono esters of corticoids |
DE2144405A1 (de) * | 1971-09-04 | 1973-03-08 | Merck Patent Gmbh | Verfahren zur herstellung von estern der pregnanreihe |
DE2826257C3 (de) * | 1978-06-15 | 1980-12-04 | Beiersdorf Ag, 2000 Hamburg | Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt |
-
1978
- 1978-03-29 JP JP53036251A patent/JPS6040439B2/ja not_active Expired
-
1979
- 1979-03-08 GB GB7908189A patent/GB2020291B/en not_active Expired
- 1979-03-14 AR AR275802A patent/AR221717A1/es active
- 1979-03-20 DE DE2910899A patent/DE2910899C2/de not_active Expired
- 1979-03-26 US US06/024,111 patent/US4290962A/en not_active Expired - Lifetime
- 1979-03-27 IT IT48501/79A patent/IT1116531B/it active
- 1979-03-28 FR FR7907832A patent/FR2421180A1/fr active Granted
- 1979-03-28 CH CH286179A patent/CH638227A5/fr not_active IP Right Cessation
-
1984
- 1984-08-07 SG SG555/84A patent/SG55584G/en unknown
- 1984-12-07 KE KE3481A patent/KE3481A/xx unknown
-
1985
- 1985-12-30 MY MY791/85A patent/MY8500791A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2421180A1 (fr) | 1979-10-26 |
JPS54128560A (en) | 1979-10-05 |
DE2910899A1 (de) | 1979-10-11 |
SG55584G (en) | 1985-03-08 |
US4290962A (en) | 1981-09-22 |
CH638227A5 (fr) | 1983-09-15 |
FR2421180B1 (es) | 1982-10-22 |
JPS6040439B2 (ja) | 1985-09-11 |
IT1116531B (it) | 1986-02-10 |
DE2910899C2 (de) | 1986-02-13 |
KE3481A (en) | 1985-01-04 |
MY8500791A (en) | 1985-12-31 |
IT7948501A0 (it) | 1979-03-27 |
GB2020291B (en) | 1982-10-06 |
GB2020291A (en) | 1979-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR221717A1 (es) | Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona | |
ES486786A0 (es) | Un procedimiento para la preparacion de carboxialquil-dipep-tidos. | |
ES495376A0 (es) | Un procedimiento para preparar un compuesto de 1,8-naftiri- dina | |
ES512401A0 (es) | "un procedimiento para preparar derivados de tetralina". | |
ES506893A0 (es) | Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4-tetrahidro-1-naftalenami-na. | |
ES476994A0 (es) | Procedimiento para preparar perhalociclopropanocarboxilatos. | |
ES479988A0 (es) | Un procedimiento para la preparacion de nuevos derivados - hete rociclicos. | |
ES486425A0 (es) | Un procedimiento para preparar nuevas 4-arilpiperinas. | |
AR231308A1 (es) | Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina | |
ES491221A0 (es) | Un procedimiento para preparar un compuesto de 1,8-naftiri- dina | |
ES517459A0 (es) | Un procedimiento para preparar un dentifrico estable. | |
ES481478A0 (es) | Procedimiento para preparar o-metaliloxifenol. | |
ES490101A0 (es) | Un procedimiento para obtener 2,6-diaminonebularinas | |
ES489127A0 (es) | Un procedimiento para la preparacion de nuevos 1, 2, 4-tria-zoles. | |
MX5790E (es) | Procedimiento para preparar 1,2,3-tiadiazol-5-il ureas | |
ES493798A0 (es) | Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona | |
ES493760A0 (es) | Un procedimiento para preparar benzoxazepinas. | |
ES508064A0 (es) | "un procedimiento para preparar derivados de halofenil-piridil-alilamina". | |
ES492115A0 (es) | Un procedimiento para la preparacion de 10, 11-dihidro-5-h- dibenzo (a,d) ciclohepten -5,10-iminas | |
ES493497A0 (es) | Un procedimiento para preparar 1,2-dihidro-2-oxo-5-(piridi- nil)nicotinonitrilo | |
ES487034A0 (es) | Un procedimiento para la preparacion de nuevas penenias sus-tituidas. | |
ES527278A0 (es) | Un procedimiento para obtener 2,5-anhidro-3,4,6-tri-o-acil-d-alonselenocarboxamida | |
ES493015A0 (es) | Un procedimiento para la preparacion de octahidro-1h-pirro- lo-(2,3g)isoquinolinas | |
ES494226A0 (es) | Procedimiento para preparar un 1,2,4-triazol-3-tiol | |
AR226418A1 (es) | Un procedimiento para preparar compuestos de 2,4-dicloro-piridina |